[0] => 
    [1] => diagnostics
    [2] => department-of-nuclear-medicines
    [3] => research-activities-nuclear-medicine-department
    [4] => 

Research Activities in the Nuclear Medicine Department

Learning is a continuous process and research is the best way of doing it. Sharing your experience will not only help others and but also give credits to your hard work. We, as nuclear medicine department, have created a customs of research for continuous learning and sharing. Our published articles here:

  1. Gupta M, Choudhury PS, Nag S, Gupta P. An original case of lip metastasis, from non small cell lung cancer. Hell J Nucl Med 2010;13:173-174.
  2. Gupta M, Choudhary PS, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med 2014;29:38-39.
  3. Gupta M, Choudhury PS, Nag S, Gupta P. Stimulated high serum thyroglobulin with negative whole body imaging do not warrant an aggressive diagnostic and therapeutic approach in differentiated thyroid cancer patients: A follow-up of 5 years or till recurrence. Hellinic Journal of Nuclear Medicine 2015;18:207-214.
  4. Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid stimulating hormone levels. Indian J Nucl Med 2015;30:16-20.
  5. Gupta M, Choudhury PS, Dsouza M, Louis R, Datta A, Mishra A. 18F-FES PET-CT Scan turns out a problem solving modality in an ER positive metastatic breast cancer patient. American Journal of Cancer Case Reports 2015,3:215-220.
  6. Chauhan D, Rawat S, Sharma MK, Ahlawat P, Pal M, Gupta G, et al. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas. J Can Res Ther 2015;11:746-51.
  7. Gupta M, Choudhury PS, Gupta G, Gandhi J. Metastasis in urothelial carcinoma mimicking prostate cancer metastasis in Ga-68 prostate-specific membrane antigen positron emission tomography-computed tomography in a case of synchronous malignancy. Indian J Nucl Med 2016;31:222-4.
  8. Dewan A, Sharma SK, Dewan AK, Khurana R, Gupta M, Pahuja A, et al. Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus. J Gastrointest Cancer. 2017;48:42-49.
  9. Gupta M, Datta A, Choudhury PS, Dsouza M, Batra U, Mishra A. Can 18F-Fluoroestradiol positron emission tomography become a new imaging standard in the estrogen receptorpositive breast cancer patient: A prospective comparative study with 18F-Fluorodeoxyglucose positron emission tomography?. World J Nucl Med 2017;16:133-9.
  10. Gupta M, Choudhury PS, Singh S, Mehta A. Exceptional Therapeutic Outcome of Metastatic Neuroendocrine Tumor with Peptide Receptor Radionuclide Therapy with Brief Review of Literature. J Nucl Med Radiat Ther 2017;8:333. doi:10.4172/2155-9619.1000333
  11. Gupta M, Choudhury P S, Hazarika D, Rawal S. A Comparative Study of 68Gallium-Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography and Magnetic Resonance Imaging for Lymph Node Staging in High Risk Prostate Cancer Patients: An Initial Experience. World J Nucl Med 2017;16:186-91.
  12. Choudhury P, Gupta M. Dual Target Molecular Imaging in precision management of breast cancer: The time has come Medical Research Archives, Vol. 5, Issue 9, September 2017.
  13. Gupta M, Choudhury PS, Goel HC, Rawal S, Talwar V (2017) Is PSMA PET-CT Better than Bone Scan? When and Why? J Nucl Med Radiat Ther. 2017,8: 342. doi:10.4172/2155-9619.1000342.
  14. Choudhury P, Gupta M. Personalized & Precision Medicine in Cancer: A Theranostic Approach. Curr Radiopharm. 2017 Nov 10;10(3):166-170.
  15. Gupta M, Choudhury PS, Rawal S, Gupta G. Incremental value of 68-gallium-prostate-specifi c membrane antigen positron emission tomography/computed tomography in patients with abnormal prostate-specific antigen and benign transrectal ultrasound biopsy. Urol Ann. 2018; 10(2):150-153.
  16. Tanwar P, Gandhi JS, Sharma A, Gupta M, Choudhary PS. Unusual metastasis of medullary thyroid carcinoma to the breast: A cytological and histopathological correlation. J Cytol 2018 April-June;35:117-20.
  17. Agrawal CR, Dutta K, Doval DC, Pasricha S, Gupta M. Breast cancer recurrence presenting as solitary intraparotid nodal metastasis detected by 18F-Fluorodeoxyglucose positron emission tomography: A very unusual occurrence. Indian J Nucl Med 2018 July-Sept;33:233-6.
  18. Gupta M, Choudhury PS, Rawal S, Goel HC, Singh A, Talwar V, et al. Initial risk stratification and staging in prostate cancer with prostatic specific membrane antigen PET/CT: A first-stop-shop. World J Nucl Med 2018 Oct-Dec;17:261-269
  19. Gupta M, Choudhury PS, Singh S, Hazarika D. Liver functional volumetry by Tc 99m Mebrofenin hepatobiliary scintigraphy before major liver resection: A game changer. Indian J Nucl Med 2018 Oct-Dec;33:277-283
  20. Gupta M, Choudhury PS, Rawal S, Goel HC, Rao SA. Evaluation of RECIST, PERCIST, EORTC and MDA criteria for assessing treatment response with Ga68-PSMA PET-CT in metastatic prostate cancer patient with biochemical progression: A comparative study. Nucl Med Mol Imaging 2018;52:420.
  21. Gupta M, Choudhury PS, Rawal S, Goel HC, Rao SA. Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography. Urol Ann 2019;11:155-62.
  22. M Gupta, P S Choudhury, S Rawal, H C Goel, V Talwar, K D Dutta, A Singh. 9P Safety profile and therapeutic efficacy of one cycle of [177Lu]prostate-specific membrane antigen (PSMA) in end stage metastatic castration-resistant prostate cancer patients with low performance status. Annals of Oncology, 2019; 30, Issue Supplement_1, February 2019.
  23. Gupta, M., Choudhury, P.S., Rawal, S. et al. Safety Profile and Therapeutic Efficacy of One Cycle of Lu177-PSMA in End-Stage Metastatic Castration-Resistant Prostate Cancer Patients with Low Performance Status. Nucl Med Mol Imaging. 2019.53,423-431.
  24. Sharma M, Goyal S, Gupta M, Batra U, Jajodia A, Babu VP. A rare case of cardiac metastasis from non-small cell lung cancer. J Indian coll cardiol 2019;9:50-1.
  25. Shrestha R, Tripathi R, Goyal P, Agarwal C, Gupta M, Mehta A, et al. Long-Term Survival in an Esophageal Cancer Patient with Multiple Recurrences. Journal of gastrointestinal cancer. 2020,51,695-697.
  26. Sharma M, Babu VP, Goyal S, Durga G, Gupta M, Gupta N. Primary Squamous Cell Carcinoma of Stomach: A Rare PresentationAsian Journal of Oncology 2020; 6(01): 32-34. DOI: 10.1055/s-0040-1701392.
  27. Gupta M, Choudhury PS, Premsagar IC, Gairola M, Ahlawat P. Role of 68Ga-Prostate-Specific Membrane Antigen PET/CT in Disease Assessment in Glioblastoma Within 48 Hours of Surgery. Clin Nucl Med. 2020 Mar;45:204-205.
  28. Gupta M, Choudhury PS, Gairola M, Premsagar IC, Rao SA. Pseudo-progression on 68Ga-Prostate Specific Membrane Antigen-11 PET/CT in a treated glioblastoma. Clin Nucl Med. 2020 Aug;45(8):621-622.
  29. Pasricha S, Durga G, Gupta G, Jajodia A, Koyyala VPB, Sharma A, Kamboj M, Gupta M, Mehta A. Primary Malignant Rhabdoid Tumour of the Liver in Adult Male: a Diagnostic and Therapeutic Challenge. J Gastrointest Cancer. 2020 Aug 13. doi: 10.1007/s12029-020-00474-0. Epub ahead of print. PMID: 32789765.
  30. Goel S, Aggarwal A, Iqbal A, Gupta M, Rao A, Singh S. 18-FDG PET-CT should be included in preoperative staging of gall bladder cancer. Eur J Surg Oncol. 2020 Sep;46(9):1711-1716.
  31. Gupta M, Karthikeyan G, Choudhury PS, Babu Koyyala VP, Sharma M, Jain P, Talwar V, Singh A, Rawal S. A Walk with Lu-177 PSMA: How Close we Have Reached from Bench to Bedside? Cancer Invest. 2020 Sep;38(8-9):486-492.
  32. Doval DC, Tripathi R, Gupta M, Mehta A, Goyal P, Agrawal C, Jain S, Upreti K, Varghese S. Unusual case of ductal breast carcinoma with vulvar metastasis. Breast J. 2020 Nov;26(11):2255-2256.
  33. Gupta M, Karthikeyan G, Choudhury PS, Sharma A, Rawal S. Clinical outcome of Lu-177 PSMA in metastatic castration-resistant prostate cancer: An initial experience from a tertiary care cancer hospital. Ann. Cancer Res. Ther. 2020 Dec; 28 (2):156-163.
  34. Manoj Gupta, G Karthikeyan, Partha Sarathi Choudhury, Anurag Sharma, Amitabh Singh, Sudhir Rawal. Is 177Lu-PSMA an effective treatment modality for mCRPC patients with bone and visceral metastasis? Hell J Nucl Med. 2020 Sep-Dec;23(3):312-320.
  35. Pasricha S, Bansal D, Batra U, Durga G, Kamboj M, Gupta G, Sharma A, Pahuja A, Jajodia A, Jain V, Gupta M, B Koyyala VP, Mehta A. Metastatic low-grade myoepithelial carcinoma of lung managed with low-dose external beam radiotherapy. Indian J Pathol Microbiol. 2021;64(1):155-157.
  36. Gupta M, Choudhury PS, Singh A, Rawal S. Oligometastasis to testis in prostate cancer: Role of 68Ga-PSMA PET/CT. World J Nucl Med. 2021;20:113-6.
Our Locations
  • Sir Chotu Ram Marg, Sector – 5, Rohini Institutional Area, Rohini, New Delhi, Delhi – 110085, India

    +91-11-47022222 | Fax +91 11 27051037

  • Squadron Leader Mahender Kumar Jain Marg, Block K, Niti Bagh, New Delhi, Delhi 110049

    +91-11-45822222 / +91-11-45822200

All © reserved to Rajiv Gandhi Cancer Institute & Research Centre
Website Designing & SEO by Techmagnate